Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Revenue of $182.5 million, a 48 percent increase over the same period in 2023 Increase in 2024 revenue guidance to $675 – $700 million, from $640 – $670 million Net income per common share of...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.99 | 1.74633974246 | 56.69 | 59.535 | 56.14 | 853395 | 58.57847228 | CS |
| 4 | 9.03 | 18.5611510791 | 48.65 | 61.663 | 46.3807 | 1013719 | 55.05410649 | CS |
| 12 | 23.4443 | 68.4791022237 | 34.2357 | 61.663 | 33.66 | 1004326 | 48.23174585 | CS |
| 26 | 26.18 | 83.1111111111 | 31.5 | 61.663 | 28.04 | 970175 | 40.27486913 | CS |
| 52 | 32.07 | 125.224521671 | 25.61 | 61.663 | 20.84 | 1128495 | 31.51290835 | CS |
| 156 | 36 | 166.051660517 | 21.68 | 61.663 | 15.825 | 958380 | 26.45469353 | CS |
| 260 | 44.44 | 335.649546828 | 13.24 | 61.663 | 9.7 | 988031 | 23.00879299 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
